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OutbreakAbstract Ebola virus disease outbreak in West Africa sends an alarming message to all countries
in the world, to increase the level of coordination and application of preventive measures globally to
avoid a disastrous epidemic in the World, as the current situation in West Africa is critical especially
after the World Health Organization increased the alarming level to an emergency in public health
all over the world. Viral hemorrhagic fevers are important because they can readily spread within a
hospital or mortuary setting, there is no effective cure or vaccine, they have a high mortality rate
and they are difﬁcult to recognize and diagnose rapidly. WHO has recommended respiratory pro-
tection for HCWs performing certain tasks such as aerosol-generating procedures, laboratory pro-
cedures, and autopsies. Particulate respirators are designed to help reduce the wearer’s exposure to
certain airborne particles. The most effective way to block aerosolized particles is to use either a
half-face or a full-face respirator. HCWs still need shoe covers, a full face respirator and latex or
nitrile gloves to decrease the risk of Ebola virus contamination.
ª 2015 The Author. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Ebola virus disease outbreak in West Africa sends an alarming
message to all countries in the world, to increase the level of
coordination and application of preventive measures globally
to avoid a disastrous epidemic in the World, as the current
situation in West Africa is critical especially after the World
Health Organization increased the alarming level to an emer-
gency in public health all over the world [1]. Ebola virus dis-
ease is a severe, often fatal disease in humans and nonhuman
primates such as monkeys, gorillas, and chimpanzees [2].
Ebola virus is one of the causes of viral hemorrhagic fever
(VHF) [3]. Viral hemorrhagic fever describes a severe, multi-
organ disease in which the vascular system is damaged and
the body’s ability to regulate itself is impaired. VHFs are often
accompanied by hemorrhages which can be life threatening.
Viral hemorrhagic fevers are important because they can read-
ily spread within a hospital or mortuary setting, there is no
effective cure or vaccine, they have a high mortality rate and
they are difﬁcult to recognize and diagnose rapidly [4].
The ﬁrst cases of Ebola virus disease (EVD) were reported
in 1976 in the Democratic Republic of Congo and since then
sporadic cases and small scale outbreaks have occurred in cen-
tral African countries [5]. There are ﬁve strains of EV but the
Zaire strain is the most severe, with a case-fatality rate up to
90% [6]. The unprecedented scale of the current outbreak of
EVD in Sierra Leone, Guinea, Liberia and Nigeria, led to
the World Health Organization [7,8,5] declaring an interna-
tional public health emergency. The outbreak has since spread
to Senegal, and a reportedly unrelated outbreak has since
occurred in the Democratic Republic of Congo (World
Health Organization) [9]. As of 22nd August 2014, the West
African outbreak has resulted in 2615 cases and 1427 deaths
and is unprecedented because it has continued for more than
double the length of time of the largest previous outbreak in
Uganda in 2000 (3 months vs. 8 months), has resulted in more
than six times as many cases (425 cases vs. 2615 cases), and has
for ﬁrst time occurred in more than one country simultane-
ously and in capital cities [10,5]. Among the total cases, 1251
have been laboratory conﬁrmed, and genetic sequencing has
showed that the similarity of the virus to the Zaire EV is
97% [11]. Unlike past outbreaks, the current outbreak of
EVD has not been contained and has resulted in social unrest,
breakdown in law and order, shortages of personal protective
equipment (PPE) and depletion of the healthcare workforce,
with over 240 health care workers (HCWs) becoming infected
and 120 HCW deaths (WHO) [5,12]. The inability to contain
this outbreak has been blamed variously on lapses in infection
control, shortages of PPE and other supplies, myths and mis-
conceptions about EVD, and the fact that it is occurring in
large cities rather than small villages. HCWs, many of whom
are nurses, are on the frontline of the response, and their occu-
pational health and safety is critical to control of the outbreak
and maintenance of the health workforce during a crisis. The
Centers for Disease Control and Prevention (CDC) [13,14]and World Health Organization (WHO) [7–9] have recom-
mended the use of respirators.
Ebola virus disease (EVD)
Ebola virus disease is a severe acute viral illness often charac-
terized by the sudden onset of fever, intense weakness, muscle
pain, headache and sore throat. This is followed by vomiting,
diarrhea, rash, impaired kidney and liver function, and in some
cases, both internal and external bleeding [14,15]. Outbreaks of
Ebola have occurred sporadically in parts of Africa, South
America, the Middle East and Eastern Europe, with fatality
rates ranging up to 90% [1].
Modes of transmission of Ebola
Ebola is spread through direct contact with blood or body ﬂuids
(including, but not limited to urine, saliva, sweat, feces, vomit,
breast milk and semen) of an infected person or animal, or
through contact with objects that have been contaminated with
the blood or other body ﬂuids of an infected person, dead or
alive [14,16]. Transmission is believed to occur via contact with
mucous membranes and non-intact skin (i.e., rashes, cuts, etc.).
Risk of infection by inhalation of contaminated aerosols by
healthcare workers has not been documented but is thought
to be low at this time based on case history evidence [15,17].
Ebola virus is readily killed by soap, bleach, direct sunlight, or
drying. Machine washing clothes that have been contaminated
with ﬂuids will destroy Ebola virus. Ebola virus survives only
a short time on surfaces that are in the sun or have dried [18].
Factors to be considered in making recommendations for
respiratory protection of HCWs
When determining recommendations for the protection of
HCWs, a risk analysis approach is required that takes into
account all relevant factors which could impact on the occupa-
tional health and safety of HCWs (Fig. 1). The severity of the
outcome (case-fatality rate and disease severity) must be
considered [19]. Any level of uncertainty around modes of
transmission must also be evaluated, particularly if the disease
has a high case-fatality rate. In addition, the availability of pre-
and post-exposure prophylaxis or treatment must be consid-
ered. The immune status and co-morbidities in HCWs should
also be considered, as some HCWs may be innately more
vulnerable to infection [20].
As the aging of the nursing workforce occurs in developed
countries, there is likely to be a high proportion of HCWs with
chronic conditions. In this case, facemasks have been recom-
mended for HCWs by CDC and WHO because of the assump-
tion that EV is not transmitted via the airborne route [13,8].
However, there is uncertainty about transmission, the conse-
quences of EVD infection are severe and there is no proven
treatment, vaccine or post-exposure prophylaxis. Recommend-
Figure 1 Factors to consider in making recommendations for respiratory protection of health care workers.
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tions than for inﬂuenza, which has a far lower case-fatality rate
and for which there are easily accessible vaccines and antiviral
therapy [21].
Further, numerous HCWs have succumbed to EVD during
this epidemic, including senior physicians experienced in treat-
ing EVD and presumably less likely to have suffered lapses in
infection control [7]. The high case-fatality rate warrants the
use of better protection such as a respirator and full body suit
with face shield, where it can be provided [18].
WHO recommendation for personal protection equipment
(PPE) against Ebola virus disease
WHO emphasizes the importance of consistent use and
implementation of Standard Precautions by all health care
workers when providing care to all patients, regardless of their
diagnoses. These precautions include a wide range measures,
including the use of PPE [5–8].
The prevention of Ebola virus infection depends on avoid-
ing contact with blood and body ﬂuids of infected individuals
and with objects contaminated with these ﬂuids. Barrier
precautions are used to prevent skin or mucous membrane
exposure of the eyes, nose, and mouth with blood, other body
ﬂuids, secretions (including respiratory droplets), or excre-
tions. For those working to control the Ebola virus disease
(EVD) outbreak and treat patients, WHO recommends that
all health care workers have the mucous membranes of their
eyes, mouth and nose completely covered by PPE. The recom-
mended personal protective equipment for most activities is
included in Table 1 [8].
Some tasks require additional body protection. Certain
tasks––including administering aerosol-generating medical
procedures, certain laboratory tasks, and autopsies––require
respiratory protection [7].Hand hygiene is strongly emphasized. It is of the highest
importance that hand hygiene be performed thoroughly and
often, including before and after donning and before and after
dofﬁng PPE. The WHO states that a risk assessment must be
done by competent experts appointed by the employer [6–9].
PPE should be selected based primarily on the potential expo-
sures and need for protection against infective ﬂuids and
agents. However, work conditions, environmental conditions,
tasks and accessibility to decontamination facilities should also
be considered [21].
Health workers should be trained on the risks, mitigating
effects of the PPE, and their use. Training should be manda-
tory and thorough followed by mentoring before workers
engage in any activities. PPE can help provide a barrier to
infectious material. However, it is very important that all local
infection control protocols and manufacturer’s user instruc-
tions be followed when removing (dofﬁng) the equipment to
avoid contamination [18].
Respiratory protection for HCWs
Surgical/medical masks or respirators are another type of PPE
recommended for those in contact with potential EVD cases.
These products may need to be ﬂuid resistant depending upon
the eye and face protection being worn. A respirator is a device
designed to help provide the wearer with respiratory protection
against inhalation of a hazardous atmosphere. To help reduce
nose, mouth and respiratory system exposures to airborne
particles (<100 lm), particulate-ﬁltering respirators are often
recommended [1,12]. Particulate respirators are available as:
1. A ﬁltering half face piece respirator, where the ﬁlter is the
entire respirator.
2. An elastomeric (reusable) half mask with a particulate
ﬁlter.
Table 1 Summary of WHO PPE Recommendations by Task.
Task Recommended PPE
Work in patient areas  Gloves
 Gown: disposable impermeable
 Medical mask
 Eye protection (eye visor, goggles or face shield)
 Shoes: closed, puncture and ﬂuid resistant (e.g. rubber boots)
Strenuous tasks or exposure to blood
and body ﬂuids
 Gloves, double set
 Gown: disposable impermeable
 Apron: waterproof (if gown is not impermeable)
 Medical mask
 Eye protection (eye visor, goggles or face shield)
 Boots: rubber or disposable overshoes and leg coverings with shoes
Aerosol generating medical procedures  Gloves
 Gown: disposable impermeable
 Respirator: FFP2, NIOSH N95 or equivalent
 Eye protection (eye visor, goggles or face shield)
 Shoes: closed, puncture and ﬂuid resistant (e.g. rubber boots)
Handling infectious waste  Gloves, heavy duty/ rubber
 Gown: impermeable
 Eye Protection (eye visor, goggles or face shield);); Goggles preferred for liquid handling
 Shoes: closed, puncture and ﬂuid resistant (e.g. rubber boots)
Laboratory personnel handling potential
Ebola specimens
 Gloves
 Gown: disposable impermeable
 Respirator*
 Eye Protection (eye visor, goggles or face shield)
 Shoes: closed with overshoes or boots*FFP2, NIOSH N95 or equivalent for handling. PAPR for
aliquoting, centrifugation or other aerosol generating procedures
Handling of human remains  Gloves, double
 Gown: disposable impermeable
 Mask
 Eye protection (eye visor, goggles or face shield)
 Rubber boots or closed puncture or ﬂuid resistant shoes and overshoes
Autopsies of known or suspected Ebola
virus disease cases
 Gloves, double
 Gown: disposable impermeable
 Respirator: FFP2, NIOSH N95 or equivalent or a PAPR
 Eye protection (eye visor, goggles or face shield)
 Shoes: closed or boots
642 H.M. Mohammed3. An elastomeric (reusable) full face piece with a particulate
ﬁlter.
4. A powered air purifying respirator (PAPR) that includes a
particulate ﬁlter.
5. A supplied air respirator.
Particulate respirators are designed to help reduce the
wearer’s exposure to certain airborne particles. Currently,
health authorities have not documented EVD as being trans-
mitted from infected individuals via airborne Ebola virus.
However, droplets containing the Ebola virus that have become
aerosolized (e.g. from coughing, sneezing, vomiting, medical
procedures, and surfaces etc.) may have the potential to come
into contact with a person’s mucous membranes in their nose
or mouth or non-intact skin. Therefore, respiratory protection
may be helpful in providing a barrier to help prevent infectious
materials from contacting a wearer’s mucous membranes. They
may also help limit inadvertent touching of the nose, mouth
and/or eyes (if a full-face piece or powered-air respirator is
used). Respiratory protection is recommended for workersperforming certain tasks such as aerosol-generating procedures,
laboratory procedures, and autopsies [16,19].
Why N95 masks are not enough: use full face respirators for real
protection
This explains why N95 masks are not enough for protecting
from Ebola. Most people do not know this, but N95 masks
are actually designed to prevent the person who is wearing
the mask from infecting others. These masks are NOT
designed to protect the wearer from a contagion ﬂoating
around in the air [17]. The only truly effective way to block
aerosolized particles is to use either a half-face respirator or
a full-face respirator (Fig. 2). Both 3 M, North Safety and
MSA Safety Works all make highly effective respirators in half
face and full face conﬁgurations. If HCWs wear only a half-
face respirator, they will need to also protect their eyes,
because Ebola virus easily enters through their eye ducts
[19,18].
Figure 2 Demonstrates standard respiratory protection for
HCWs with either a half-face respirator or a full-face respirator.
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Bleach kills Ebola, so it is a good idea to stock up on some
bleach right now. Any protective gear that HCWs wear in pub-
lic may acquire Ebola contamination on its surfaces, so they
will need to decontaminate their gear using a water-bleach
solution each time after wearing their gear anywhere near
Ebola patients or in areas where Ebola contamination may
have occurred. Disposable gear, of course, does not need to
be washed but it does need to be carefully contained in a bio-
hazard containment/ disposable vessel such as being sealed
inside trash bags which are then placed inside sturdy barrels
or other containers [18,19,5].
For decontamination scrub-down, this is usually a two-
person operation, where the person wearing the suit stands
in an isolated room or a makeshift outdoor shower and is
meticulously scrubbed down with bleach and water by a sec-
ond person doing the scrubbing and rinsing. This second per-
son, of course, must also be wearing isolation gear or order to
minimize their own risk of acquiring an infection from the
washing process [18]. HCWs must keep in mind that a body
suit does not offer full protection against Ebola all by itself.
They still need shoe covers, a full face respirator and latex or
nitrile gloves. Even then, risk of contamination is not reduced
to zero. There is always a risk that a few Ebola particles slip
through the edges of the gear and end up on your body [12,14].
Ideally, HCWs should be scrubbed and rinsed while wear-
ing their gear, then they should remove the gear and strip
down to being completely nude. They should then move to a
different location where they experience a full body shower
combined with a strong bleach-water soak and scrub for the
feet [8,7,13]. All clothes should be thoroughly washed and then
dried in direct sunlight. Because UV light destroys Ebola, the
more decontamination procedures they can conduct in direct
sunlight, the better. For washing reusable gear, the best guess
right now would be 5% bleach and 95% water. Stronger lab-
oratory cleaning solutions like Triton-X are likely to be effec-
tive at even lower concentrations such as 1–2% [9,14].
In conclusion, while EVD is predominantly spread by
contact with blood and body ﬂuids, there is some uncertainty
about the potential for aerosol transmission. Particulate respi-
rators are designed to help reduce the wearer’s exposure to cer-
tain airborne particles. The most effective way to blockaerosolized particles is to use either a half-face or a full-face
respirator. HCWs still need shoe covers, a full face respirator
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